The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251.
Year: 1995
Type: article
Source: PubMed
Authors: J J Killion, P Beltran, C A O'Brian, S S Yoon, D Fan, M R Wilson, I J Fidler
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2473877617
